Awards

NOW ACCEPTING 2018 NOMINATIONS!

Nominators bear responsibility for completing all the paperwork by stated deadlines and for obtaining permission from the nominee to submit their personal curriculum vitae and supporting materials.

Please complete the nomination form to submit with your nomination. Nominations for 2018 awards are due by April 30, 2018. Please note:

  1. All award submissions are to be submitted in PDF format.
  2. All materials should be submitted in one PDF document per nominee.
  3. Completed packages should be sent to: [email protected]
  4. Confirmation of receipt of nomination will be issued within one business day of receiving. Confirmation will be sent to the nominator.
  5. Recipients are required to attend the 20th World Congress of Psycho-Oncology, October 31 to November 2, in Hong Kong and will be invited to present during a plenary session. Details on the World Congress can be found by going to http://www.ipos-society.org/world-congress/.
  6. Review of all nominations received will take place in May and June with final results emailed to each nominator in July.

Awards Criteria

  • An award recipient may receive only one Society award in any calendar year.
  • No recipient of an IPOS Award shall be eligible for nomination to a second or subsequent award within a period of 10 years from the date of their previous award.
  • Each award shall have a peer review panel consisting of at least: (a) one previous recipient of the award, (b) one member of the Federation, and (c) one member of the Awards Committee.
  • The Society Treasurer shall review, ratify where required and advise on all financial recommendations and requests made by the Awards Committee.
  • For all awards, consideration may be given for travel reimbursement and/or registration fee waiver, if required.
  • All award nominations must include a completed and signed nomination form, a letter of nomination from the nominator, two letters of support for the nomination from other individuals to whom the nominee is known, the curriculum vitae or resume of the nominee, and any additional paperwork required by the specific award for which the individual is being nominated.
  • Award recipients must be available to attend the IPOS World Congress at which the award is to be presented.
  • Specific criteria for each award are identified below.

NEW for 2018:Jimmie Holland Memorial Award
Arthur M. Sutherland Award and Memorial Lecture
Bernard Fox Memorial Award
Noemi Fisman Award for Lifetime Clinical Excellence
Hiroomi Kawano New Investigator Award
Society Distinguished Life Fellowship Award
President’s Community Award for Distinguished Contributions to IPOS

Jimmie Holland Memorial Award

The Jimmie Holland Memorial Award honors an IPOS or psycho-oncology community member recognized for making a unique contribution considered to be a highly creative or pioneering innovation or activity that advances the field of Psycho-oncology. The award is unique in its recognition as Jimmie Holland as a pioneer and chief innovator of our time, as well as recognizes her enormous contribution as mentor.

This award is considered for nominees within early to senior levels of careers with documentation and support to provide clear evidence of what is “visionary or outside the box” about the activity and how it represents an outstanding idea or activity or line of work, within the chosen area of the field of psycho-oncology.

It is important that the nominator provide evidence in his/her letter of recommendation that the nominee meets the criteria. In addition, the nominator needs to provide two further letters of recommendation from other individuals to whom the nominee is known which, provides evidence that the nominee meets these criteria. The nominee should not have received any other IPOS award previously.

The award will be launched and presented during the President´s Plenary session recognizing Jimmie Holland at the IPOS Congress in Hong Kong. The award recipient will be invited to make a few brief remarks related to their specific enterprise or vision.

  • IPOS nomination form, signed by nominee
  • Letter of nomination from the nominator, specifying why the nominee meets the award description above
  • Two letters of support from other individuals to whom the nominee is known, also specifying why the nominee meets the award description above.

Arthur M. Sutherland Award and Memorial Lecture

The Arthur M. Sutherland Award honors an IPOS or psycho-oncology community member with a lifetime achievement in the field of psycho-oncology. This is a late career award and recognizes sustained and distinguished output in psycho-oncology over their whole career. This is the Society’s most important award and reflects the international standing of the recipient.

The recipient will have achieved international recognition for his/her work and be considered to have contributed important innovations to the field of psycho-oncology. Quantity of output is less important than evidence of international standing and innovation across an individual’s whole career. It is important that the nominator provides evidence in their letter of recommendation that the nominee meets these criteria. In addition, the nominator needs to provide two further letters of recommendation from other individuals to whom the nominee is known, which provide evidence that the nominee meets these criteria.

This award will be presented at the next IPOS World Congress of Psycho-Oncology. The award recipient will be invited to present an overview on a topic related to their research as part of a plenary session of the IPOS World Congress. Additionally, the Sutherland Award recipient may be invited to publish an article in the official journal of IPOS, Psycho-Oncology, at the discretion of the journal’s Editorial Board.

  • IPOS Award Nomination Form, signed by the nominee
  • Nominee’s curriculum vitae or resume
  • Letter of nomination from the nominator, specifying why the nominee meets the award description above
  • Two letters of support from other individuals to whom the nominee is known, also specifying why the nominee meets the award description above

[top of page]

Bernard Fox Memorial Award

The Bernard Fox Memorial Award honors an IPOS or psycho-oncology community member who has made an outstanding contribution in education or research to the field of psycho-oncology. The primary focus is on the academic and educational output of the nominee.

This is a mid to late career award, and the nominee may work as an educator, as a researcher and/or provide clear evidence of being a leader in his/her chosen area of psycho-oncology. It is important that the nominator provides evidence in his/her letter of recommendation that the nominee meets these criteria. In addition, the nominator needs to provide two further letters of recommendation from other individuals to whom the nominee is known, which provide evidence that the nominee meets these criteria.

This award will be presented at the next IPOS World Congress of Psycho-Oncology. The award recipient will be invited to present an overview on a topic related to their research as part of a plenary session of the IPOS World Congress.

  • IPOS Award Nomination Form, signed by the nominee
  • Nominee’s curriculum vitae or resume
  • Letter of nomination from the nominator, specifying why the nominee meets the award description above
  • Two letters of support from other individuals to whom the nominee is known, also specifying why the nominee meets the award description above

[top of page]

Noemi Fisman Award for Lifetime Clinical Excellence

The Noemi Fisman Award for Lifetime Clinical Excellence honors an IPOS or psycho-oncology community member in recognition of outstanding clinical contributions to the field of psycho-oncology. He/she must have served for a major proportion of his/her career as a clinician and be able to demonstrate novel, beneficial and substantial initiatives impacting directly on the care of patients and his/her families either through their own practice or practice developments.

Candidates must be licensed and have been actively practicing in the field of clinical psycho-oncology for a minimum of 20 years. The award focuses on the distinctive contribution made in developing services to patients and families. Innovation and sustained successful clinical service of outstanding character should be what distinguishes the recipient of this award. It is important that the nominator provide evidence in his/her letter of recommendation that the nominee meets these criteria. In addition, the nominator needs to provide two further letters of recommendation from other individuals to whom the nominee is known, which provide evidence that the nominee meets these criteria.

This award will be presented at the IPOS World Congress of Psycho-Oncology. The award recipient may be asked to provide a brief overview of his/her work (5 minutes) at the IPOS World Congress.

  • IPOS Award Nomination Form, signed by the nominee
  • Nominee’s curriculum vitae or resume
  • Letter of nomination from the nominator, specifying why the nominee meets the award description above
  • Two letters of support from other individuals to whom the nominee is known, also specifying why the nominee meets the award description above

[top of page]

Hiroomi Kawano New Investigator Award

The Hiroomi Kawano New Investigator Award honors a new investigator for outstanding research contributions in the field of psycho-oncology and is an early career award. Candidates must be within seven years of active work in psycho-oncology after completing his/her postgraduate, fellowship or equivalent specialist training (defined as a PhD or MD or equivalent). This award is sponsored by the Hiroomi Kawano Foundation in Japan.

The award is linked to professional attainment rather than to age. Recipients are distinguished by the level and quality of research output at this early career stage. It is important that the nominator provides evidence in his/her letter of recommendation that the nominee meets these criteria. In addition, the nominator needs to provide two further letters of recommendation from other individuals to whom the nominee is known, which provide evidence that the nominee meets these criteria.

This award will be presented at the IPOS World Congress of Psycho-Oncology. The award recipient may be asked to provide a brief overview of his/her work (5 minutes) at the IPOS World Congress.

  • IPOS Award Nomination Form, signed by the nominee
  • Nominee’s curriculum vitae or resume, with details of specific termination dates of degrees and post-graduate training
  • Letter of nomination from the nominator, who must be an Active Member of IPOS or a full member of any national psycho-oncology society, specifying why the nominee meets the award description above
  • Two letters of support from other individuals to whom the nominee is known, also specifying why the nominee meets the award description above
  • A statement from the nominee, not to exceed 500 words, that highlights significant research accomplishments in the area of psycho-oncology
  • Copies of up to four publications that represent the candidate’s research work

[top of page]

Society Distinguished Life Fellowship Award

The Society Distinguished Life Fellowship Award recognizes extraordinary and notable contributions to the organization and success of IPOS. This award is only for one who has made a singular contribution to the Society and its work. The Distinguished Life Fellowship Award is limited to past or present IPOS members.

The award shall carry with it Honorary Life Membership in IPOS, with a special plaque for the fellow. The award shall also include waived IPOS membership dues and the possibility of waived World Congress registration fees at the Congress at which the award is presented. Nominees should be, or have been, members of IPOS for at least 10 years and are not eligible if not a member within the past five years.

Nominations for this award can only be made by the IPOS Board of Directors.

The IPOS Awards Committee shall select recipients of IPOS awards. If no suitable nominations are received, no awards will be given.

[top of page]

President’s Community Award for Distinguished Contributions to IPOS

The President’s Community Award for Distinguished Contributions to IPOS is a discretionary award that is made to an individual, group or organization in the community that, in the opinion of the Board has made an outstanding contribution of great significant to the Society.

  1. Nominations are made by a member of the IPOS Board and all nominations must be seconded by two members of the Board and approved by a two-thirds of the Board.
  2. Given the special nature of this award, it is envisaged that it will be awarded only occasionally.
  3. The awardee shall receive a plaque and citation from the Board and s/he (or a representative, if an organization is the recipient) shall be invited to receive these at the World Congress. Congress fees maybe be waived on this occasion.

[top of page]

Congratulations to the IPOS 2017 Award Winners!

2017 Arthur M. Sutherland Award and Memorial Lecture Recipient

Professor Matthew Loscalzo, LCSW

Matthew J. Loscalzo is the Liliane Elkins Professor in Supportive Care Programs in the Department of Supportive Care Medicine and Professor in Department of Population Sciences. He is also the Executive Director of the Department of Supportive Care Medicine and the Administrative Director of the Sheri & Les Biller Patient and Family Resource Center at the City of Hope-National Medical Center, Duarte California, USA.

Professor Loscalzo has over 37 years experience in caring for cancer patients and their families.  He is recognized internationally as a pioneer in the clinical, educational, and research domains of psychosocial aspects of cancer.  Professor Loscalzo was the President of the American Psychosocial Oncology Society and the Association of Oncology Social Workers. He is highly recognized and sought after for his strategic mentorship of leaders across disciplines. Professor Loscalzo has focused pain and palliative care, the implementation of problem-based screening programs, gender-based medicine and problem solving therapies. Along with James Zabora, ScD, they created the first prospective universal clinical biopsychosocial screening program in the United States.

Professor Loscalzo has held leadership positions at Memorial Sloan-Kettering Cancer Center, the Johns Hopkins Oncology Center, the Rebecca and John Moores Cancer Center at the University of California at San Diego and is now in his 10 year at City of Hope-National Medical Center. He has created a number of highly integrated interdisciplinary biopsychosocial programs based on a unique staff leadership model.

In 2010, he received the Outstanding Education and Training Award Recipient from the American Psychosocial Oncology Society. In October 2014, Professor Loscalzo was recognized for a lifetime achievement award in clinical care with the Noemi Fisman Award for Lifetime Clinical Excellence from the International Psycho-Oncology Society. In August 2015, he received the Jimmie Holland Life Time Leadership Award from the American Psychosocial Oncology Society.

He is the PI on two 5 year NIH R25E training grants (teaching health care professionals how to build supportive care programs and biopsychosocial screening programs) and a site PI for a new third R25E to teach advanced cognitive behavioral skills. He is also on the editorial boards or a reviewer for a number of professional journals and has over 75 publications. His clinical interests are gender-based medicine, strengths-based approaches to psychotherapies, problem-based distress screening and the creation of supportive care programs.

2017 Bernard Fox Memorial Award Recipient

Dr. Gary Rodin, MD

Gary Rodin is the University of Toronto/University Health Network Harold and Shirley Lederman Chair in Psychosocial Oncology and Palliative Care and Head of the Department of Supportive Care at Princess Margaret Cancer Centre in Toronto, Canada. Dr. Rodin is also the Director of the Global Institute of Psychosocial, Palliative and End-of-Life Care (GIPPEC) and a Professor of Psychiatry at the University of Toronto. He leads a clinical and research program on the psychosocial dimensions of advanced and terminal disease and on the development and evaluation of novel interventions to improve the quality of life and the quality of dying and death in this population. These integrated psychosocial and palliative interventions include Managing Cancer and Living Meaningfully (CALM), a supportive-expressive psychotherapeutic treatment for patients with metastatic cancer and their caregivers, and an integrated emotion and symptom-focused intervention for individuals diagnosed with life-threatening hematological malignancies . Through GIPPEC, a University of Toronto Interdisciplinary Institute based at Princess Margaret, Dr. Rodin has established international partnerships in Europe, Asia, Africa and the Middle East to contribute to global access to palliative and supportive care for patients and families facing advanced disease and the end of life. He has published widely in these areas and is recognized internationally for his efforts to improve the rigor of research and the effectiveness and availability of psychosocial and palliative interventions.

2017 Noemi Fisman Award for Lifetime Clinical Excellence Recipient

Chun-Kai Fang, MD, MSc, PhD

I am the first psychiatrist to involve palliative medicine and psycho-oncology in Taiwan. Since 1998, I involved clinical services of hospice palliative care in MacKay Hospice and Palliative Care Center as a psychiatric consultant. Since 2006, I began to attend the annual conferences of the International Psycho-Oncology Society (IPOS) every year. Under the encouragement of senior professionals in the IPOS, I funded the Taiwan Psycho-Oncology Society (TPOS) on October 25, 2009, and became the first TPOS president. Via deep communication with Taiwanese government, I and my colleagues began to provide nationwide education programs, clinical service systems, and researches of psycho-oncology since 2010. After our effort, psycho-oncology services had been an important necessary part of cancer care in Taiwan since 2013. In 2017, under authorized by Taiwanese government, I am the program investigator of the 3-year nationwide psycho-oncology program to build the standardized psycho-oncology services, training courses for certification, and clinical guideline.

2017 Hiroomi Kawano New Investigator Award Recipient

Dr. Michelle Peate

Dr. Michelle Peate is the Program Leader for the Psychosocial Health and Wellbeing Research Unit (emPoWeR) Unit based at the Department of Obstetrics and Gynaecology, University of Melbourne and a National Breast Cancer Foundation (NBCF) Early Career Fellow. In her current role she is overseeing a number of research projects in psycho-oncology. Her main goals involve the development of resources for people who need them, and their evaluation through prospective, multi-centre studies. Her research portfolio has involved the development and implementation of a number of patient resources, including a fertility-related decision aid for young women with early breast cancer (now available from the Breast Cancer Network Australia) and a booklet on breast cancer and early menopause (available from the National Breast and Ovarian Cancer Centre). Her work in this area is both nationally and internationally recognised.  Current projects include the development of an online fertility-related decision aid for young women with early breast cancer with low health literacy and an online fertility-related decision aid for parents of children with cancer. She is also developing an online fertility ‘calculator’ for young women with breast cancer.  To keep up to date on her progress with these studies you can follow her on twitter @DrPeate.


2017 President’s Community Award for Distinguished Contributions to IPOS Recipient

Dr Andreas Ullrich MD, MPH

Dr Andreas Ullrich MD, MPH, is Adviser to the Assistant Director General Noncommunicable Diseases and Mental Health (NMH cluster) with the World Health Organization (WHO) at WHO Headquarters Geneva.

Dr Ullrich graduated in Medicine from the University of Munich, Germany, got his doctorate at the Max Planck Institute for Psychiatry Munich with his innovative study about stress among oncologist and oncology nurses. He then specialised in internal medicine through a clinical career at primary (Munich) secondary (Dresden) and tertiary level of care (University of Berlin). After completion of his medical specialization he studied and graduated in Public Health at the Bielefeld School of Public Health, Germany where he worked as assistant professor in cancer epidemiology.

He joined WHO at Headquarters Geneva in 2001, working on its cancer control program which is aimed at providing global guidance to WHO Member States in cancer control planning and capacity building. He has since has shaped the WHO cancer control strategy with the development of a organization-wide cancer prevention and control technical network which is engaging all relevant WHO programmes at Headquarters and Regional Offices in responding to the needs of cancer control in low-and middle-income countries. The translation of the results of cancer research into public health practice is Dr Ullrich’s focus as liaison officer between WHO and the International Agency for Research on Cancer (IARC), WHO’s cancer research institute in Lyon/France. In order to facilitate the dissemination and implementation of WHO’s guidance and tools at national level, Dr Ullrich is leading the developing partnerships with governmental, non-governmental organizations and WHO collaborating centers. One major focus of his collaborative work is to join WHO with professional organizations such as IPOS and others such as ESMO (European Society of Medical Oncology) and SIOP (International Society of Childhood Oncology). Having IPOS as partner of WHO is instrumental to translate global WHO guidance on patient centered care and palliative care into national capacity building efforts.

View the list of previous IPOS Award winners